{"entity":{"type":"insider","cik":"0001346986","url":"/insider/0001346986","json_url":"/insider/0001346986.json","name":"MPM Asset Management Investors 2005 BVIII LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":15,"first":"2005-12-22","last":"2012-07-10","span_basis":"filed_date"},"name_variants":[{"name":"MPM Asset Management Investors 2005 BVIII LLC","source":"filing","n_filings":15,"first_seen":"2005-12-22","last_seen":"2012-07-10"}],"transactions":[{"id":2650626,"accession":"0001209191-12-037740","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-037740","line_url":"/filing/0001209191-12-037740#line-2","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM BIOVENTURES III L.P.; MPM BIOVENTURES III-QP L.P.; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GP L.P.; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG","owner_display_name":"MPM BIOVENTURES III PARALLEL FUND, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1624574.0,"shares_display":"1,624,574","price_per_share":0.307,"price_display":"0.31","price_state":"stated","total_value":498744.218,"total_display":"498,744.22","total_whole":"498,744","shares_owned_after":1275886.0,"shares_owned_after_display":"1,275,886","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-07-09","filed_date":"2012-07-10","scope":"insider"},{"id":2650619,"accession":"0001209191-12-037740","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-037740","line_url":"/filing/0001209191-12-037740#line-1","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM BIOVENTURES III L.P.; MPM BIOVENTURES III-QP L.P.; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GP L.P.; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG","owner_display_name":"MPM BIOVENTURES III PARALLEL FUND, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":671217.0,"shares_display":"671,217","price_per_share":0.291,"price_display":"0.29","price_state":"stated","total_value":195324.147,"total_display":"195,324.15","total_whole":"195,324","shares_owned_after":2900460.0,"shares_owned_after_display":"2,900,460","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-07-06","filed_date":"2012-07-10","scope":"insider"},{"id":2988204,"accession":"0001209191-12-037230","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-037230","line_url":"/filing/0001209191-12-037230","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III GP L.P.; MPM BIOVENTURES III L.P.; MPM BIOVENTURES III-QP L.P.; MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III LLC","owner_display_name":"MPM BIOVENTURES III GMBH & CO. Beteiligungs KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":178558.0,"shares_display":"178,558","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":51781.82,"total_display":"51,781.82","total_whole":"51,782","shares_owned_after":3571677.0,"shares_owned_after_display":"3,571,677","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-07-02","filed_date":"2012-07-05","scope":"insider","n_lines":2},{"id":2820604,"accession":"0001209191-12-036057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-036057","line_url":"/filing/0001209191-12-036057#line-1","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III-QP L.P.; MPM BIOVENTURES III L.P.; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GP L.P.","owner_display_name":"MPM BIOVENTURES III GMBH & CO. Beteiligungs KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19500.0,"shares_display":"19,500","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":5655.0,"total_display":"5,655.00","total_whole":"5,655","shares_owned_after":3750235.0,"shares_owned_after_display":"3,750,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-06-28","filed_date":"2012-07-02","scope":"insider"},{"id":2869268,"accession":"0001209191-12-034922","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-034922","line_url":"/filing/0001209191-12-034922#line-1","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III L.P.; MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM BIOVENTURES III-QP L.P.; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GP L.P.","owner_display_name":"MPM BIOVENTURES III L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":3480.0,"total_display":"3,480.00","total_whole":"3,480","shares_owned_after":3769735.0,"shares_owned_after_display":"3,769,735","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-06-19","filed_date":"2012-06-21","scope":"insider"},{"id":3382314,"accession":"0001209191-12-034488","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-034488","line_url":"/filing/0001209191-12-034488#line-1","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III L.P.; MPM BIOVENTURES III-QP L.P.; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP L.P.","owner_display_name":"MPM BIOVENTURES III L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1450.0,"shares_display":"1,450","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":420.5,"total_display":"420.50","total_whole":"421","shares_owned_after":3781735.0,"shares_owned_after_display":"3,781,735","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-06-15","filed_date":"2012-06-19","scope":"insider"},{"id":2535523,"accession":"0001209191-12-032790","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-032790","line_url":"/filing/0001209191-12-032790#line-2","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III LLC; MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM BIOVENTURES III-QP L.P.; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III L.P.; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III GP L.P.","owner_display_name":"MPM BIOVENTURES III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8400.0,"shares_display":"8,400","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":2436.0,"total_display":"2,436.00","total_whole":"2,436","shares_owned_after":3783185.0,"shares_owned_after_display":"3,783,185","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-06-06","filed_date":"2012-06-07","scope":"insider"},{"id":2535519,"accession":"0001209191-12-032790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-032790","line_url":"/filing/0001209191-12-032790#line-1","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III LLC; MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM BIOVENTURES III-QP L.P.; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III L.P.; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III GP L.P.","owner_display_name":"MPM BIOVENTURES III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29555.0,"shares_display":"29,555","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":8570.95,"total_display":"8,570.95","total_whole":"8,571","shares_owned_after":3791585.0,"shares_owned_after_display":"3,791,585","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-06-05","filed_date":"2012-06-07","scope":"insider"},{"id":2987669,"accession":"0001209191-12-031975","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-12-031975","line_url":"/filing/0001209191-12-031975#line-6","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP L.P.; MPM BIOVENTURES III LLC; MPM BIOVENTURES III L.P.; MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III-QP L.P.","owner_display_name":"MPM Asset Management Investors 2005 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29850.0,"shares_display":"29,850","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":8955.0,"total_display":"8,955.00","total_whole":"8,955","shares_owned_after":3821140.0,"shares_owned_after_display":"3,821,140","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-31","filed_date":"2012-06-04","scope":"insider"},{"id":2987663,"accession":"0001209191-12-031975","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-12-031975","line_url":"/filing/0001209191-12-031975#line-5","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP L.P.; MPM BIOVENTURES III LLC; MPM BIOVENTURES III L.P.; MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III-QP L.P.","owner_display_name":"MPM Asset Management Investors 2005 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51007.0,"shares_display":"51,007","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":15302.1,"total_display":"15,302.10","total_whole":"15,302","shares_owned_after":3850990.0,"shares_owned_after_display":"3,850,990","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-30","filed_date":"2012-06-04","scope":"insider"},{"id":2987658,"accession":"0001209191-12-031975","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-12-031975","line_url":"/filing/0001209191-12-031975#line-4","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP L.P.; MPM BIOVENTURES III LLC; MPM BIOVENTURES III L.P.; MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III-QP L.P.","owner_display_name":"MPM Asset Management Investors 2005 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15300.0,"shares_display":"15,300","price_per_share":0.3021,"price_display":"0.30","price_state":"stated","total_value":4622.13,"total_display":"4,622.13","total_whole":"4,622","shares_owned_after":3901997.0,"shares_owned_after_display":"3,901,997","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-29","filed_date":"2012-06-04","scope":"insider"},{"id":2987652,"accession":"0001209191-12-031975","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-12-031975","line_url":"/filing/0001209191-12-031975#line-3","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP L.P.; MPM BIOVENTURES III LLC; MPM BIOVENTURES III L.P.; MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III-QP L.P.","owner_display_name":"MPM Asset Management Investors 2005 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":293015.0,"shares_display":"293,015","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":87904.5,"total_display":"87,904.50","total_whole":"87,905","shares_owned_after":3917297.0,"shares_owned_after_display":"3,917,297","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-25","filed_date":"2012-06-04","scope":"insider"},{"id":2987647,"accession":"0001209191-12-031975","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-031975","line_url":"/filing/0001209191-12-031975#line-2","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP L.P.; MPM BIOVENTURES III LLC; MPM BIOVENTURES III L.P.; MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III-QP L.P.","owner_display_name":"MPM Asset Management Investors 2005 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135250.0,"shares_display":"135,250","price_per_share":0.3004,"price_display":"0.30","price_state":"stated","total_value":40629.1,"total_display":"40,629.10","total_whole":"40,629","shares_owned_after":4210312.0,"shares_owned_after_display":"4,210,312","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-23","filed_date":"2012-06-04","scope":"insider"},{"id":2987641,"accession":"0001209191-12-031975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-031975","line_url":"/filing/0001209191-12-031975#line-1","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP L.P.; MPM BIOVENTURES III LLC; MPM BIOVENTURES III L.P.; MPM BIOVENTURES III PARALLEL FUND, L.P.; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III-QP L.P.","owner_display_name":"MPM Asset Management Investors 2005 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":287000.0,"shares_display":"287,000","price_per_share":0.3031,"price_display":"0.30","price_state":"stated","total_value":86989.7,"total_display":"86,989.70","total_whole":"86,990","shares_owned_after":4345562.0,"shares_owned_after_display":"4,345,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-22","filed_date":"2012-06-04","scope":"insider"},{"id":5769821,"accession":"0001209191-09-051752","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-051752","line_url":"/filing/0001209191-09-051752#line-3","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP LP; MPM BIOVENTURES III LP; MPM BIOVENTURES III QP LP; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III PARALLEL FUND, LP","owner_display_name":"MPM Asset Management Investors 2005 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152052.0,"shares_display":"152,052","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":1292442.0,"total_display":"1,292,442.00","total_whole":"1,292,442","shares_owned_after":6363249.0,"shares_owned_after_display":"6,363,249","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-11-09","filed_date":"2009-11-09","scope":"insider"},{"id":5769819,"accession":"0001209191-09-051752","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-051752","line_url":"/filing/0001209191-09-051752#line-2","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP LP; MPM BIOVENTURES III LP; MPM BIOVENTURES III QP LP; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III PARALLEL FUND, LP","owner_display_name":"MPM Asset Management Investors 2005 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":264648.0,"shares_display":"264,648","price_per_share":8.0581,"price_display":"8.06","price_state":"stated","total_value":2132560.0488,"total_display":"2,132,560.05","total_whole":"2,132,560","shares_owned_after":6515301.0,"shares_owned_after_display":"6,515,301","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-11-06","filed_date":"2009-11-09","scope":"insider"},{"id":5769817,"accession":"0001209191-09-051752","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-051752","line_url":"/filing/0001209191-09-051752#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP LP; MPM BIOVENTURES III LP; MPM BIOVENTURES III QP LP; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III PARALLEL FUND, LP","owner_display_name":"MPM Asset Management Investors 2005 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78262.0,"shares_display":"78,262","price_per_share":8.0025,"price_display":"8.00","price_state":"stated","total_value":626291.655,"total_display":"626,291.66","total_whole":"626,292","shares_owned_after":6779949.0,"shares_owned_after_display":"6,779,949","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-11-05","filed_date":"2009-11-09","scope":"insider"},{"id":5729102,"accession":"0001209191-09-036127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-036127","line_url":"/filing/0001209191-09-036127#line-1","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III LP; MPM BIOVENTURES III LLC; MPM BIOVENTURES III PARALLEL FUND, LP; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP LP; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III QP LP","owner_display_name":"MPM BIOVENTURES III LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1276593.0,"shares_display":"1,276,593","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":1340422.65,"total_display":"1,340,422.65","total_whole":"1,340,423","shares_owned_after":4632562.0,"shares_owned_after_display":"4,632,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-07-08","filed_date":"2009-07-09","scope":"insider"},{"id":7239027,"accession":"0001209191-07-029282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-029282","line_url":"/filing/0001209191-07-029282#line-1","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III QP LP; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III LP; MPM BIOVENTURES III PARALLEL FUND, LP; MPM BIOVENTURES III GP LP","owner_display_name":"MPM BIOVENTURES III QP LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72900.0,"shares_display":"72,900","price_per_share":18.2348,"price_display":"18.23","price_state":"stated","total_value":1329316.92,"total_display":"1,329,316.92","total_whole":"1,329,317","shares_owned_after":3355969.0,"shares_owned_after_display":"3,355,969","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-08","filed_date":"2007-05-10","scope":"insider"},{"id":6999291,"accession":"0001209191-07-028679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-028679","line_url":"/filing/0001209191-07-028679#line-1","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III PARALLEL FUND, LP; MPM BIOVENTURES III QP LP; MPM BIOVENTURES III LP; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GP LP","owner_display_name":"MPM BIOVENTURES III PARALLEL FUND, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":68400.0,"total_display":"68,400.00","total_whole":"68,400","shares_owned_after":3428869.0,"shares_owned_after_display":"3,428,869","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-04","filed_date":"2007-05-08","scope":"insider"},{"id":8234190,"accession":"0001209191-07-027721","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-027721","line_url":"/filing/0001209191-07-027721#line-2","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III QP LP; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III LP; MPM BIOVENTURES III PARALLEL FUND, LP; MPM BIOVENTURES III GP LP","owner_display_name":"MPM BIOVENTURES III QP LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":675.0,"shares_display":"675","price_per_share":18.03,"price_display":"18.03","price_state":"stated","total_value":12170.25,"total_display":"12,170.25","total_whole":"12,170","shares_owned_after":3432669.0,"shares_owned_after_display":"3,432,669","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-02","filed_date":"2007-05-03","scope":"insider"},{"id":8234187,"accession":"0001209191-07-027721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-027721","line_url":"/filing/0001209191-07-027721#line-1","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III QP LP; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III LP; MPM BIOVENTURES III PARALLEL FUND, LP; MPM BIOVENTURES III GP LP","owner_display_name":"MPM BIOVENTURES III QP LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31925.0,"shares_display":"31,925","price_per_share":18.0726,"price_display":"18.07","price_state":"stated","total_value":576967.755,"total_display":"576,967.76","total_whole":"576,968","shares_owned_after":3433344.0,"shares_owned_after_display":"3,433,344","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-01","filed_date":"2007-05-03","scope":"insider"},{"id":8506222,"accession":"0001209191-07-026598","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-026598","line_url":"/filing/0001209191-07-026598#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"MPM BIOVENTURES III QP LP; MPM BIOVENTURES III PARALLEL FUND, LP; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III LP; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GP LP","owner_display_name":"MPM BIOVENTURES III QP LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900000.0,"shares_display":"900,000","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":5697000.0,"total_display":"5,697,000.00","total_whole":"5,697,000","shares_owned_after":6858211.0,"shares_owned_after_display":"6,858,211","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-30","filed_date":"2007-05-01","scope":"insider"},{"id":8506218,"accession":"0001209191-07-026589","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-026589","line_url":"/filing/0001209191-07-026589#line-2","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP LP; MPM BIOVENTURES III LP; MPM BIOVENTURES III QP LP; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III PARALLEL FUND, LP","owner_display_name":"MPM Asset Management Investors 2005 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19500.0,"shares_display":"19,500","price_per_share":18.0626,"price_display":"18.06","price_state":"stated","total_value":352220.7,"total_display":"352,220.70","total_whole":"352,221","shares_owned_after":3465269.0,"shares_owned_after_display":"3,465,269","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-30","filed_date":"2007-05-01","scope":"insider"},{"id":8506215,"accession":"0001209191-07-026589","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-026589","line_url":"/filing/0001209191-07-026589#line-1","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GP LP; MPM BIOVENTURES III LP; MPM BIOVENTURES III QP LP; MPM BIOVENTURES III LLC; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III PARALLEL FUND, LP","owner_display_name":"MPM Asset Management Investors 2005 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43100.0,"shares_display":"43,100","price_per_share":18.0691,"price_display":"18.07","price_state":"stated","total_value":778778.21,"total_display":"778,778.21","total_whole":"778,778","shares_owned_after":3484769.0,"shares_owned_after_display":"3,484,769","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-27","filed_date":"2007-05-01","scope":"insider"},{"id":1649518,"accession":"0001209191-05-065281","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-065281","line_url":"/filing/0001209191-05-065281#line-2","is_derivative":false,"issuer_cik":"0001173408","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001173408","owner_cik":null,"owner_name":"MPM BIOVENTURES III LLC; MPM BIOVENTURES III PARALLEL FUND, LP; MPM BIOVENTURES III GP LP; MPM Asset Management Investors 2005 BVIII LLC; MPM BIOVENTURES III GMBH & CO. Beteiligungs KG; MPM BIOVENTURES III QP LP; MPM BIOVENTURES III LP","owner_display_name":"MPM BIOVENTURES III LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":318000.0,"shares_display":"318,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":3498000.0,"total_display":"3,498,000.00","total_whole":"3,498,000","shares_owned_after":3527874.0,"shares_owned_after_display":"3,527,874","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-12-20","filed_date":"2005-12-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001339455","name":"Somaxon Pharmaceuticals, Inc.","url":"/issuer/0001339455","role":"Ten percent owner","n_filings":13,"first_seen":"2005-12-22","last_seen":"2012-07-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000755806","name":"PONIARD PHARMACEUTICALS, INC.","url":"/issuer/0000755806","role":"Ten percent owner","n_filings":2,"first_seen":"2007-05-01","last_seen":"2009-11-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001346986","retrieved_at":"2026-08-22T15:10:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}